Avokadio

Breath-powered metabolic health platform that helps prevent diabetes and reduce chronic disease costs for individuals, care providers, and health insurers.

Specialty Solutions Startup Seed

Visit Website

Overview

Avokadio is a Turkish health technology startup that uses patented breath analysis technology to prevent and manage diabetes and other chronic metabolic diseases. The company's portable nano-sensor device measures volatile organic compounds (VOCs) -- including ketones, ammonia, nitrogen oxide, ethanol, and methane/hydrogen -- in exhaled breath to track fat-burning metabolism in real time. This biometric data is combined with reinforcement-learning algorithms to generate personalized, continuously adapting meal plans delivered through a mobile app.

The platform targets individuals with or at risk of diabetes, as well as health insurers and care providers seeking to reduce costs associated with chronic disease management. By enabling proactive preventive intervention rather than reactive treatment, Avokadio positions itself as a cost-reduction tool in the health insurance value chain. The company launched a crowdfunding campaign on Indiegogo in February 2023 and completed two clinical trials with support from Bahcesehir University.

Avokadio has participated in several major Turkish startup programs including Sabanci ARF, KWORKS (Koc University), and ITU Cekirdek, and won the ITU Big Bang Startup Challenge. The company has also established a US sales and business development presence and has received interest from Japanese partners.

Products & Services

Avokadio Breath Analyzer

A pocket-sized, patented nano-sensor hardware device that measures volatile organic compounds in exhaled breath -- including ketones, ammonia, nitrogen oxide, ethanol, and methane/hydrogen -- to score fat-burning metabolism on a 1-10 scale. Users take 3-4 daily breath measurements that feed the AI model.

Key Features

Nano-sensor technology measuring multiple VOC biomarkers
Real-time fat-burning metabolic score (1-10 scale)
Two completed clinical trials with peer-reviewed published research
Compact, portable form factor (pocket-sized)

Target Users: Individuals managing obesity, diabetes risk, or metabolic health; athletes; health insurers seeking preventive care tools

Avokadio Mobile App (iOS & Android)

A 12-month subscription platform that pairs with the breath analyzer device, providing AI-driven personalized nutrition coaching that continuously adapts to user preferences, dietary restrictions, and biometric breath data.

Key Features

Personalized AI-generated meal plans adapting to user breath data and preferences
Behavioral change coaching
Integration with breath analyzer data
Dietary restriction support
Basic exercise suggestions

Target Users: Individual consumers; health insurer wellness program participants